The Anti-Depression-Like Effects of Zhengtian Capsule Via Induction of Neurogenesis and the Neurotrophic Signaling Pathway.

Liang Yang,Yong Wang,Nuomin Li,Bing Xu,Juanhui Duan,Chunxu Yuan,Qinfen Yuan,Qifan Yang,Hong Qing,Zhi Dai,Zhenzhen Quan
DOI: https://doi.org/10.3389/fphar.2020.01338
IF: 5.6
2020-01-01
Frontiers in Pharmacology
Abstract:Oxidative stress that causes neural damages in neurodegenerative disorders has been widely studied for the pathogenesis and diagnostic measures. Zhengtian capsule (ZTC), a type of traditional Chinese medicine for headaches, has been found to have extra effects in recent years, such as promoting the release of serotonin and dopamine in the brain, but its specific mechanism has not been clearly elucidated. In this study, we focus on revealing whether ZTC can regulate key proteins of neurotrophic signaling pathway to alleviate depression-like behavior caused by oxidative stress. Experimental results show that ZTC (M 0.34 and H 0.7 g/kg) can elevate the proliferation of neural stem cells and GABAergic-type neurons in the hippocampus, promote the protein levels of BDNF, phosphorylated ERK1/2, and CREB, and inhibit the expression level of a key inflammation factor NFκB in a dose-dependent manner. These data suggest ZTC acts on multiple pathways to resist excessive oxidative stress, proving it to be a potential neurotrophic drug.
What problem does this paper attempt to address?